Date published: 2025-12-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

group III sPLA2 Activators

Group III secretory phospholipase A2 (sPLA2-III) is a member of the secretory phospholipase A2 (sPLA2) family, which consists of low-molecular-weight, calcium-dependent enzymes known for their ability to hydrolyze the sn-2 acyl bond of phospholipids, releasing free fatty acids and lysophospholipids. These enzymes are involved in diverse physiological functions, including lipid metabolism, host defense, and the initiation of the inflammatory response.

The sPLA2-III protein is distinct from other sPLA2 enzymes in its structure and catalytic properties. It possesses a unique and extended N-terminal region not found in other sPLA2s, which may influence its substrate specificity and interaction with cellular membranes or other proteins. sPLA2-III's enzymatic activity is further characterized by its preference for phosphatidylglycerol-containing membranes, and it has been shown to have a relatively high hydrolytic activity against bacterial membranes, suggesting a role in innate immunity.Group III sPLA2 is expressed in a variety of tissues, and its expression can be induced under certain inflammatory conditions, which indicates its potential involvement in inflammation-related pathologies. The enzyme's activity leads to the production of arachidonic acid, a precursor of eicosanoids, which are potent mediators of inflammation and may also affect other signaling pathways involved in cell proliferation, differentiation, and death.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Arachidonic Acid (20:4, n-6)

506-32-1sc-200770
sc-200770A
sc-200770B
100 mg
1 g
25 g
$90.00
$235.00
$4243.00
9
(1)

As a substrate for sPLA2, Arachidonic Acid availability can indirectly enhance sPLA2-III activity by providing more substrate for enzymatic action.

Melittin

37231-28-0sc-200868
sc-200868A
sc-200868B
500 µg
1 mg
10 mg
$192.00
$332.00
$772.00
2
(1)

Melittin, a component of bee venom, has been shown to stimulate sPLA2 activity. While its direct effect on sPLA2-III is unclear, it may serve as an indirect activator.

caspase-9 inhibitor I

210345-04-3sc-3085
sc-3085A
1 mg
5 mg
$408.00
$1734.00
33
(0)

This inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) might indirectly modulate sPLA2-III activity through changes in lipid mediator dynamics.

PP 1

172889-26-8sc-203212
sc-203212A
1 mg
5 mg
$84.00
$142.00
6
(1)

While MAFP is primarily an inhibitor of cPLA2 and iPLA2, its effect on lipid mediator profiles could indirectly influence sPLA2-III activity.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$56.00
$156.00
$270.00
$665.00
37
(1)

PGE2, a product of arachidonic acid metabolism, can modulate various phospholipases and might indirectly affect sPLA2-III activity.

LTB4 (Leukotriene B4)

71160-24-2sc-201043
50 µg
$367.00
4
(1)

LTB4, another lipid mediator, can influence phospholipase activity and may have an indirect effect on sPLA2-III.

PAF C-16

74389-68-7sc-201009
sc-201009A
5 mg
25 mg
$128.00
$294.00
10
(1)

PAF is involved in lipid signaling and could indirectly affect sPLA2-III activity by modulating lipid mediator pathways.

Curcumin

458-37-7sc-200509
sc-200509A
sc-200509B
sc-200509C
sc-200509D
sc-200509F
sc-200509E
1 g
5 g
25 g
100 g
250 g
1 kg
2.5 kg
$36.00
$68.00
$107.00
$214.00
$234.00
$862.00
$1968.00
47
(1)

Curcumin affects various signaling pathways and could indirectly modulate sPLA2-III activity through its impact on lipid metabolism.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$60.00
$185.00
$365.00
64
(2)

Resveratrol influences lipid metabolism and inflammatory processes, potentially affecting sPLA2-III activity.

Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3)

6217-54-5sc-200768
sc-200768A
sc-200768B
sc-200768C
sc-200768D
100 mg
1 g
10 g
50 g
100 g
$92.00
$206.00
$1744.00
$7864.00
$16330.00
11
(1)

These fatty acids modulate lipid metabolism and inflammation, potentially influencing sPLA2-III activity.